These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 35008821

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Design, synthesis, and Structure-Activity Relationships (SAR) of 3-vinylindazole derivatives as new selective tropomyosin receptor kinases (Trk) inhibitors.
    Duan Y, Wang J, Zhu S, Tu ZC, Zhang Z, Chan S, Ding K.
    Eur J Med Chem; 2020 Oct 01; 203():112552. PubMed ID: 32702585
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Activity of Entrectinib in a Patient With the First Reported NTRK Fusion in Neuroendocrine Cancer.
    Sigal D, Tartar M, Xavier M, Bao F, Foley P, Luo D, Christiansen J, Hornby Z, Maneval EC, Multani P.
    J Natl Compr Canc Netw; 2017 Nov 01; 15(11):1317-1322. PubMed ID: 29118225
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
    Ku BM, Bae YH, Lee KY, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ.
    Invest New Drugs; 2020 Apr 01; 38(2):360-368. PubMed ID: 31124056
    [Abstract] [Full Text] [Related]

  • 27. Mechanisms of Entrectinib Resistance in a Neuroblastoma Xenograft Model.
    MacFarland SP, Naraparaju K, Iyer R, Guan P, Kolla V, Hu Y, Tan K, Brodeur GM.
    Mol Cancer Ther; 2020 Mar 01; 19(3):920-926. PubMed ID: 31871269
    [Abstract] [Full Text] [Related]

  • 28. Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3-Positive Acute Myeloid Leukemia.
    Smith KM, Fagan PC, Pomari E, Germano G, Frasson C, Walsh C, Silverman I, Bonvini P, Li G.
    Mol Cancer Ther; 2018 Feb 01; 17(2):455-463. PubMed ID: 29237803
    [Abstract] [Full Text] [Related]

  • 29. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    Kim JH, Hong JH, Choi YL, Lee JA, Seo MK, Lee MS, An SB, Sung MJ, Cho NY, Kim SS, Shin YK, Kim S, Kang GH.
    J Pathol; 2021 Dec 01; 255(4):399-411. PubMed ID: 34402529
    [Abstract] [Full Text] [Related]

  • 30. Entrectinib for the treatment of metastatic NSCLC: safety and efficacy.
    Sartore-Bianchi A, Pizzutilo EG, Marrapese G, Tosi F, Cerea G, Siena S.
    Expert Rev Anticancer Ther; 2020 May 01; 20(5):333-341. PubMed ID: 32223357
    [Abstract] [Full Text] [Related]

  • 31. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
    Zhang X, Zhu M, Wang H, Song Z, Zhan D, Cao W, Han Y, Jia J.
    Gene; 2021 Jan 15; 766():145163. PubMed ID: 32980450
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells.
    Aveic S, Pantile M, Seydel A, Esposito MR, Zanon C, Li G, Tonini GP.
    Oncotarget; 2016 Feb 02; 7(5):5646-63. PubMed ID: 26735175
    [Abstract] [Full Text] [Related]

  • 34. HER3 PET Imaging Predicts Response to Pan Receptor Tyrosine Kinase Inhibition Therapy in Gastric Cancer.
    Esfahani SA, de Aguiar Ferreira C, Rotile NJ, Ataeinia B, Krishna S, Catalano OA, Caravan P, Yen YF, Heidari P, Mahmood U.
    Mol Imaging Biol; 2023 Apr 02; 25(2):353-362. PubMed ID: 35962301
    [Abstract] [Full Text] [Related]

  • 35. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ, Lin S, Liu JN, Zhang MB, Du YT, Zhang DD, Xu WH, Wang HB.
    J Cell Physiol; 2019 Aug 02; 234(10):18587-18601. PubMed ID: 30953349
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. INC280 inhibits Wnt/β-catenin and EMT signaling pathways and its induce apoptosis in diffuse gastric cancer positive for c-MET amplification.
    Sohn SH, Kim B, Sul HJ, Kim YJ, Kim HS, Kim H, Seo JB, Koh Y, Zang DY.
    BMC Res Notes; 2019 Mar 11; 12(1):125. PubMed ID: 30871613
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.